Rosyrah Kit
Product Images NDC 70700-312

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rosyrah (NDC 70700-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ethinyl Estradiol Structural Formula (Ethinyl Estradiol Structure)

This is the chemical formula and molecular weight of Ethinyl Estradiol, a synthetic form of the naturally occurring female sex hormone, estradiol. It is commonly used in combination with progestin as a component of hormonal contraceptives. Its molecular formula is C20H24O2 and the molecular weight is 296.4 g/mol.*

FDA Label Image

Figure 1: Likelihood Of Developing A Vte (Figure 1)

This text provides a visual representation in Figure 1 of the likelihood of developing VTE (Venous Thromboembolism) in different circumstances such as being non-pregnant, a non-COC (Combined Oral Contraceptive) user, a COC-user, during pregnancy, and postpartum. It includes ranges of VTE occurrences per 10,000 Women Years (WY) for each scenario. The pregnancy data is noted to be based on actual pregnancy duration in reference studies and the rate is between 7 to 27 per 10,000 WY, assuming a nine-month pregnancy duration.*

FDA Label Image

Figure 2: Percent Of Women Taking Levonorgestrel And Ethinyl Estradiol Tablets And Ethinyl Estradiol Tablets Who Reported Unscheduled Bleeding And/or Spotting (Figure 2)

FDA Label Image

Figure 3: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Figure 3)

This is a list showing comparisons between Ever COC vs. Never COC use in various studies such as the NICHD Women's Care Study by Marchbanks PA in 2002, the French ESN cohort Study by Dumaiue V in 2005, the Shanghai Women's Health Study by Darigoshoa in 2009, the Nurses' Health Study by Huriur DJ in 2010, the Oxford Family Planning Study by Vessey M in 2013, and more recent studies like the Danish Sex Hormone Register Study by Moreh LS in 2017. It includes data on the effect estimates in terms of odds ratio (OR), relative risk (RR), and hazard ratio (HR).*

FDA Label Image

Levonorgestrel Structural Formula (Levonorgestrel Structure)

Levonorgestrel is a compound with the molecular formula C21H 250 and a molecular weight of 312.4. It is commonly used as a progestin in hormonal contraceptives and emergency contraceptive pills. Levonorgestrel works by preventing ovulation and changing the cervical mucus to inhibit sperm penetration.*

FDA Label Image

Blister Card (Image 03)

This is a product label for a medication called Rosyrah™ which contains Levonorgestrel and Ethinyl Estradiol Tablets. The tablets come in different strengths (0.15mg/0.02mg, 0.15mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg) and each pack contains 28 tablets. The NDC (National Drug Code) for this medication is 7070031267.*

FDA Label Image

Blister Card (Image 04)

This text provides information about a medication with the NDC code 7070031287, named Rosyrah™, containing Levonorgestrel and Ethinyl Estradiol Tablets in different doses, ranging from 0.15 mg/0.02mg to 0.15 mg/0.03 mg. The medication comes in packs of 28 tablets.*

FDA Label Image

Blister Card (Image 05)

FDA Label Image

Carton (Image 06)

This is a product description for a pouch containing an extended-cycle tablet blister pack with 91 tablets of Levonorgestrel and Ethinyl Estradiol Tablets. The tablets have different combinations of strengths ranging from 0.15mg/0.02mg to 0.15mg/0.03mg. The text also mentions instructions for the pharmacist to dispense enclosed patient information with each prescription and not to separate the blister cards. It appears to be a pharmaceutical product intended for hormonal contraception.*

FDA Label Image

Pregnancy Chart (Pregnancy Chart)

This text explains information on the number of pregnancies per 100 women in one year, different methods of contraception such as implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal rings with hormones, condoms, diaphragm, avoiding sex during fertile days of the monthly cycle, spermicide, withdrawal method, and mentions the option of no birth control.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.